Combined pretrauma scopolamine and phencyclidine attenuate posttraumatic increased sensitivity to delayed secondary ischemia

L. W. Jenkins, B. G. Lyeth, W. Lewelt, K. Moszynski, D. S. Dewitt, R. L. Balster, L. P. Miller, G. L. Clifton, Douglas Dewitt, R. L. Hayes

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Fasted Wistar rats were given a mild level of traumatic brain injury (TBI) and then subjected to 6 min of transient forebrain ischemia 24 h posttrauma. One group was given simultaneous 1 mg/kg scopolamine and 4 mg/kg phencyclidine intraperitoneally (IP) 15 min before trauma and another group an equal volume of plasmalyte A solution. After 7 days of postinjury survival, placebo-treated rats demonstrated increased posttraumatic vulnerability to secondary ischemic CA1 neuronal death even 24 h after trauma. This finding confirmed that increased posttraumatic ischemic vulnerability persists for at least 24 h even following mild trauma. Combined muscarinic receptor and N-methyl-D-aspartate (NMDA) receptor coupled ion channel blockade given and present during the mild TBI statistically attenuated this enhanced secondary ischemic CA1 neuronal death and thus posttraumatic increased ischemic vulnerability. Placebo-treated rats had 335.3 ± 93.6 CA1 neurons/106μm2 and drug-treated rats had 844.8 ± 184.9 CA1 neurons/106μm2. This result suggests that muscarinic and/or NMDA receptor-mediated events confined to TBI and the early posttraumatic period are in part responsible for the phenomenon of increased posttraumatic ischemic vulnerability.

Original languageEnglish (US)
Pages (from-to)275-287
Number of pages13
JournalJournal of Neurotrauma
Volume5
Issue number4
StatePublished - 1988
Externally publishedYes

Fingerprint

Phencyclidine
Scopolamine Hydrobromide
Brain Concussion
Ischemia
N-Methyl-D-Aspartate Receptors
Wounds and Injuries
Placebos
Neurons
Muscarinic Receptors
Prosencephalon
Ion Channels
Cholinergic Agents
Wistar Rats
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Jenkins, L. W., Lyeth, B. G., Lewelt, W., Moszynski, K., Dewitt, D. S., Balster, R. L., ... Hayes, R. L. (1988). Combined pretrauma scopolamine and phencyclidine attenuate posttraumatic increased sensitivity to delayed secondary ischemia. Journal of Neurotrauma, 5(4), 275-287.

Combined pretrauma scopolamine and phencyclidine attenuate posttraumatic increased sensitivity to delayed secondary ischemia. / Jenkins, L. W.; Lyeth, B. G.; Lewelt, W.; Moszynski, K.; Dewitt, D. S.; Balster, R. L.; Miller, L. P.; Clifton, G. L.; Dewitt, Douglas; Hayes, R. L.

In: Journal of Neurotrauma, Vol. 5, No. 4, 1988, p. 275-287.

Research output: Contribution to journalArticle

Jenkins, LW, Lyeth, BG, Lewelt, W, Moszynski, K, Dewitt, DS, Balster, RL, Miller, LP, Clifton, GL, Dewitt, D & Hayes, RL 1988, 'Combined pretrauma scopolamine and phencyclidine attenuate posttraumatic increased sensitivity to delayed secondary ischemia', Journal of Neurotrauma, vol. 5, no. 4, pp. 275-287.
Jenkins, L. W. ; Lyeth, B. G. ; Lewelt, W. ; Moszynski, K. ; Dewitt, D. S. ; Balster, R. L. ; Miller, L. P. ; Clifton, G. L. ; Dewitt, Douglas ; Hayes, R. L. / Combined pretrauma scopolamine and phencyclidine attenuate posttraumatic increased sensitivity to delayed secondary ischemia. In: Journal of Neurotrauma. 1988 ; Vol. 5, No. 4. pp. 275-287.
@article{04ba60ad6d014973808dc7f7df2d18d4,
title = "Combined pretrauma scopolamine and phencyclidine attenuate posttraumatic increased sensitivity to delayed secondary ischemia",
abstract = "Fasted Wistar rats were given a mild level of traumatic brain injury (TBI) and then subjected to 6 min of transient forebrain ischemia 24 h posttrauma. One group was given simultaneous 1 mg/kg scopolamine and 4 mg/kg phencyclidine intraperitoneally (IP) 15 min before trauma and another group an equal volume of plasmalyte A solution. After 7 days of postinjury survival, placebo-treated rats demonstrated increased posttraumatic vulnerability to secondary ischemic CA1 neuronal death even 24 h after trauma. This finding confirmed that increased posttraumatic ischemic vulnerability persists for at least 24 h even following mild trauma. Combined muscarinic receptor and N-methyl-D-aspartate (NMDA) receptor coupled ion channel blockade given and present during the mild TBI statistically attenuated this enhanced secondary ischemic CA1 neuronal death and thus posttraumatic increased ischemic vulnerability. Placebo-treated rats had 335.3 ± 93.6 CA1 neurons/106μm2 and drug-treated rats had 844.8 ± 184.9 CA1 neurons/106μm2. This result suggests that muscarinic and/or NMDA receptor-mediated events confined to TBI and the early posttraumatic period are in part responsible for the phenomenon of increased posttraumatic ischemic vulnerability.",
author = "Jenkins, {L. W.} and Lyeth, {B. G.} and W. Lewelt and K. Moszynski and Dewitt, {D. S.} and Balster, {R. L.} and Miller, {L. P.} and Clifton, {G. L.} and Douglas Dewitt and Hayes, {R. L.}",
year = "1988",
language = "English (US)",
volume = "5",
pages = "275--287",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Combined pretrauma scopolamine and phencyclidine attenuate posttraumatic increased sensitivity to delayed secondary ischemia

AU - Jenkins, L. W.

AU - Lyeth, B. G.

AU - Lewelt, W.

AU - Moszynski, K.

AU - Dewitt, D. S.

AU - Balster, R. L.

AU - Miller, L. P.

AU - Clifton, G. L.

AU - Dewitt, Douglas

AU - Hayes, R. L.

PY - 1988

Y1 - 1988

N2 - Fasted Wistar rats were given a mild level of traumatic brain injury (TBI) and then subjected to 6 min of transient forebrain ischemia 24 h posttrauma. One group was given simultaneous 1 mg/kg scopolamine and 4 mg/kg phencyclidine intraperitoneally (IP) 15 min before trauma and another group an equal volume of plasmalyte A solution. After 7 days of postinjury survival, placebo-treated rats demonstrated increased posttraumatic vulnerability to secondary ischemic CA1 neuronal death even 24 h after trauma. This finding confirmed that increased posttraumatic ischemic vulnerability persists for at least 24 h even following mild trauma. Combined muscarinic receptor and N-methyl-D-aspartate (NMDA) receptor coupled ion channel blockade given and present during the mild TBI statistically attenuated this enhanced secondary ischemic CA1 neuronal death and thus posttraumatic increased ischemic vulnerability. Placebo-treated rats had 335.3 ± 93.6 CA1 neurons/106μm2 and drug-treated rats had 844.8 ± 184.9 CA1 neurons/106μm2. This result suggests that muscarinic and/or NMDA receptor-mediated events confined to TBI and the early posttraumatic period are in part responsible for the phenomenon of increased posttraumatic ischemic vulnerability.

AB - Fasted Wistar rats were given a mild level of traumatic brain injury (TBI) and then subjected to 6 min of transient forebrain ischemia 24 h posttrauma. One group was given simultaneous 1 mg/kg scopolamine and 4 mg/kg phencyclidine intraperitoneally (IP) 15 min before trauma and another group an equal volume of plasmalyte A solution. After 7 days of postinjury survival, placebo-treated rats demonstrated increased posttraumatic vulnerability to secondary ischemic CA1 neuronal death even 24 h after trauma. This finding confirmed that increased posttraumatic ischemic vulnerability persists for at least 24 h even following mild trauma. Combined muscarinic receptor and N-methyl-D-aspartate (NMDA) receptor coupled ion channel blockade given and present during the mild TBI statistically attenuated this enhanced secondary ischemic CA1 neuronal death and thus posttraumatic increased ischemic vulnerability. Placebo-treated rats had 335.3 ± 93.6 CA1 neurons/106μm2 and drug-treated rats had 844.8 ± 184.9 CA1 neurons/106μm2. This result suggests that muscarinic and/or NMDA receptor-mediated events confined to TBI and the early posttraumatic period are in part responsible for the phenomenon of increased posttraumatic ischemic vulnerability.

UR - http://www.scopus.com/inward/record.url?scp=0024150522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024150522&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 275

EP - 287

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 4

ER -